MHC class II molecules assemble in the endoplasmic reticulum in a chap
erone-mediated fashion to form a nine-chain structure consisting of th
ree alpha beta dimers associated with an invariant chain trimer. This
complex is transported through the Golgi apparatus and into the endoso
mal system. The signal for endosomal targeting resides in the cytoplas
mic tail of the invariant chain. Current evidence argues that the segr
egation of the class II-invariant chain complex from the constitutive
pathway of membrane protein transport occurs in the trans-Golgi networ
k. However, class II-invariant chain complexes that reach the cell sur
face are also rapidly internalized into endosomes. Within the endosoma
l system, probably in a late endosome/prelysosome, the invariant chain
is degraded, releasing alpha beta dimers that bind peptides predomina
ntly derived from endocytosed proteins. Evidence suggests that many of
these peptides are actually generated in lysosomes. The precise mecha
nisms involved in forming class II-peptide complexes are unclear, alth
ough the existence of antigen-processing mutants argues that additiona
l gene products, at least one of which is encoded in the MHC, are invo
lved. After binding peptides, class II molecules are transported by an
unknown route to the cell surface, where their primary function of pr
esenting antigenic peptides to CD4(+) T cells is carried out.